When Does Wegovy Come to the UK — and Is It Available Now?

Step 1 (How Wegovy reached the UK market (and when)

The short answer to a question our prescribers hear most weeks: Wegovy did not 'come' to the UK at a single moment) its arrival unfolded in stages. Novo Nordisk received UK licence approval for the 2.4mg weekly injection in 2022, and private prescriptions became available shortly afterwards. NICE then published its appraisal (TA875) in March 2023, recommending semaglutide for weight management but restricting NHS use to specialist weight management services for a maximum of two years. That phased NHS rollout is why so many people still assume Wegovy has not arrived yet, and if you want the full timeline in one place, our page covering when Wegovy is coming to the UK pulls together every stage of that rollout. It has, the barrier is NHS access, not product availability. For the full background on how and when semaglutide was first approved, we have covered that separately.

The injection titration pathway runs from 0.25mg weekly up through 0.5mg, 1.0mg, 1.7mg and 2.4mg, with each step managed by the prescriber over roughly four-week intervals. The treatment targets appetite regulation through GLP-1 receptor pathways, slowing gastric emptying and increasing feelings of fullness. In the STEP 1 trial, participants lost an average of around 15% of body weight over 68 weeks at the 2.4mg maintenance dose, as published in the New England Journal of Medicine.

Step 2, The 7.2mg approval and the Wegovy tablet: what changed in 2026

Two significant regulatory decisions followed in quick succession. On 14 April 2026 the MHRA approved a dedicated single-dose 7.2mg Wegovy pen (one pre-set weekly injection) for adults with a BMI of 30 or above. Trials at this dose reported average weight loss of around 20.7% over 72 weeks, narrowing the gap with the highest tirzepatide doses. The starting dose for new patients remains 0.25mg; 7.2mg is the new ceiling, reached by the prescriber's titration schedule. If you want to understand which strengths and formats Wegovy now comes in, that page sets out the full picture.

Then on 11 June 2026 the MHRA approved Wegovy tablets (oral semaglutide co-formulated with an absorption enhancer) making the UK the first country in Europe to licence an oral GLP-1 medicine for weight management. The tablet schedule runs 1.5mg, 4mg, 9mg, then 25mg daily at maintenance, each step held for at least a month. Room-temperature storage and no needles make it a genuinely different practical option for people who prefer not to inject. You can read more about semaglutide across all its UK-licensed forms on our semaglutide overview page.

Step 3, NHS rollout: where things stand right now

NHS availability has expanded, but remains restricted. Under NICE's recommendation (TA875), Wegovy on the NHS is available through specialist weight management services, subject to BMI and comorbidity thresholds, broadly BMI 35 or above with at least one weight-related condition, or 30–34.9 where specialist-referral criteria are met. Ethnic-background thresholds are 2.5 kg/m² lower under that guidance. Treatment is capped at two years on the NHS, and patients must have multidisciplinary support in place. Waiting lists at specialist services can be considerable.

For cost context relevant to private access, our Wegovy price comparison page explains what a legitimate private prescription typically covers and why headline prices vary between providers. Private treatment sits outside NHS quotas and waiting times, but it still requires a genuine clinical assessment, suitability is decided by a prescriber, not at the point of purchase.

Step 4, Getting access today through a regulated route

If you do not currently meet NHS criteria, or simply do not want to wait, a private prescription from a GPhC-registered pharmacy is the legal alternative. The process at a service like ours runs as follows: complete a free consultation; a GPhC-registered Independent Prescriber reads your answers and medical history the same day; if clinically suitable, the prescription is issued and the medicine dispatched by 5pm for next-working-day DPD delivery. No subscription, no auto-renewal. Every repeat order is clinically re-reviewed.

What matters most when choosing a private provider is verifiability. Any online pharmacy supplying Wegovy must appear on the GPhC's pharmacy register, you can search for any service there in seconds. Sellers offering semaglutide without a prior clinical consultation are operating outside UK law; the MHRA has seized large volumes of counterfeit weight-loss pens and warns that unregulated sources carry serious safety risks. Check the register before you order anywhere.

If you are ready to find out whether treatment is right for you, speak to our prescribers through a free consultation and get a same-day clinical answer.